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Glomerular cell proliferation and PDGF expression precede glomeru.
losclerosis in the remnant kidney model. Increasing evidence supports a
role of glomerular cell proliferation in the development of focal or
diffuse glomerulosclerosis. This study investigates the chronology and
sequence of cellular events that precede glomerulosclerosis in 5/6
nephrectomized rats. Within three days of renal ablation, a phenotypic
switch occurred in which some mesangial cells expressed a-smooth
muscle actin. This was followed by proliferation of mesangial cells, and
to a lesser degree endothelial cells from day 5 to week 4 as detected by
immunostaining for the proliferating cell nuclear antigen (PCNA).
Glomerular cell proliferation was accompanied by increased immuno-
histochemical expression of PDGF B-chain. In situ hybridization
showed no glomerular PDGF B-chain mRNA expression at the induc-
tion of proliferation (day 5), and a marked increase between week 1 and
4 in operated rats. In parallel, increased expression of PDGF receptor
/3-subunit protein and mRNA was demonstrated by immunohistochem-
istry and Northern analysis of total glomerular RNA. The onset of
glomerular cell proliferation was also associated with mild glomerular
platelet accumulation (as defined by "In-labelled platelet studies) as
well as with fibrinogen deposition. Proteinuria, glomerular sclerotic
changes, and leukocyte infiltration all followed cell proliferation. The
glomerular leukocyte infiltrate consisted of monocytes/macrophages
and increased markedly at week lOin rats with renal ablation. Thus, our
results suggest that in the remnant kidney model: I) proliferation of
intrinsic glomerular cells precedes glomerulosclerosis; 2) proliferation
may be initiated by degranulating platelets and sustained by PDGF
released from intrinsic glomerular cells; and 3) glomerular monocyte/
macrophage infiltration occurs after the proliferation, and may possibly
contribute to the development of glomerular sclerotic changes.
Many renal diseases progress to end-stage renal failure with
glomerular sclerosis independent of the initial pathogenetic
mechanism [1]. This suggests that progressive renal diseases
may exhibit a common destructive pathway that leads to focal
and eventually diffuse glomerulosclerosis and chronic tubu-
lointerstitial disease. The most widely studied model of the
pathological sequelae which occur after extensive destruction
of renal parenchyma is the 5/6 nephrectomy, or remnant kidney
model [2] in rats. One of the central pathological findings in this
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model is a rapid postablation increase in glomerular size due to
increased cell numbers (hyperplasia), increased cell size (hy-
pertrophy), increased deposition of extracellular material and
capillary dilation [3—6]. Multiple pathomechanisms have been
proposed to be responsible for the ultimate development of
glomerulosclerosis in this model, including glomerular hyper-
tension and hyperfiltration [7], glomerular hypertrophy [8],
epithelial cell damage [9, 10], intracapillary thrombosis [1, 31,
macrophage influx [1, 11], macromolecule influx [1, 11—13] and
serum lipid abnormalities [14—16].
In addition to these proposed mechanisms there is increasing
evidence that mesangial cell proliferation may also be important
in the pathogenesis of mesangial expansion and the develop-
ment of focal or diffuse glomeruloscierosis. Thus, correlations
between mesangial or glomerular cell proliferation and subse-
quent development of sclerosis have been noted in minimal
change disease progressing to focal sclerosis in humans [17], in
3/4 nephrectomized rats [18] and in the anti-Thy 1.1 model of
mesangial proliferative glomerulonephritis in rats [19, 20].
Moreover, in some models platelet depletion can reduce mesan-
gial cell proliferation [21, 22], and treatment with anti-platelet
agents and non-anticoagulant heparin derivatives with antipro-
liferative activity also reduce glomerulosclerosis [23—27].
The precise mechanism(s) that lead to the proliferation of
glomerular cells in vivo are incompletely understood. Possibil-
ities include a mesangial cell response to growth factors derived
from platelets [23, 27], macrophages [1, 9, 11, 14] and endothe-
hal cells [101 or direct activation by deposited macromolecules
[1, 7, 9, 10], lipids [15, 16] or circulating or locally released
glomerular hypertrophic factors [1, 8]. In this context PDGF is
one of the most potent mesangial cell mitogens in vitro, and it
can be released not only from activated platelets, but also from
macrophages, endothelial cells and mesangial cells themselves
[28—32]. Recently, we have obtained evidence supporting a role
for PDGF in the induction of mesangial cell proliferation
following immune injury in vivo [33].
To clarify the factors involved in the induction of glomerular
cell proliferation as they relate to development of sclerosis in a
non-immune model of progressive renal disease, we have
utilized the remnant kidney model in rats to: (1) establish when
glomerular proliferation occurs, and what cell types are in-
volved; (2) correlate proliferation with platelets, thrombosis or
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infiltrating leukocytes in glomeruli; (3) determine if proliferation
is associated with increased glomerular PDGF and PDGF
receptor expression; and (4) relate these events to the later
development of proteinuria and glonierular sclerosis.
Methods
Disease model and experimental protocol
Seventy male Sprague-Dawley rats (Simonson, Gilroy, Cali-
fornia, USA) weighing 140 to 160 g at the start of the experiment
were studied. Animals were fed standard rat chow (Wayne
Rodent Blox, Animal Specialty, Hobart, Oregon, USA). In 35
rats (OP group) a right subcapsular nephrectomy and infarction
of approximately two-thirds of the left kidney was accom-
plished by ligation of the posterior and 1 or 2 anterior extrarenal
branches of the main renal artery under equithesin anesthesia
(1% sodium pentobarbital, Anthony Products, Arcadia, Califor-
nia, USA; 4.25% chloral hydrate, Spectrum Chemicals, Gar-
dena, California, USA; 0.3 ml/100 g body wt). In the control
group (SHAM) of 35 rats, a sham operation consisting of
laparotomy and manipulation of the renal pedicles but without
destruction of renal tissue was performed. Postoperative 24-
hour urinary protein excretion and serum creatinine values
were determined at days 3 and 5 as well as at weeks 1, 2, 3, 4,
7.5 and 10 in 8 to 10 randomly selected animals of both groups.
At each time point five rats from each group underwent renal
biopsy (no rat underwent more than one biopsy). At 10 weeks
the surviving rats (31 of the OP group and 35 of the SHAM
group) were sacrificed and further renal tissue specimens were
obtained. In all cases cortical biopsies were taken from the
center of the non-infarcted area only. Biopsies were studied to
quantitate and localize total and proliferating glomerular cells,
monocyte/macrophages, neutrophils, lymphocytes, mesangial
cells, and cells expressing a-smooth muscle actin, PDGF
B-chain, PDGF receptor /3-subunit and fibnnogen. In addition,
a separate experiment was performed to quantify intraglomer-
ular platelet accumulation at day 5 (10 operated and sham
operated rats) and weeks 2 and 4 (5 operated and sham operated
rats each) by the i.v. injection of 'In-labelled platelets. Fi-
nally, RNA was extracted from isolated glomeruli of operated
and sham operated rats at day 5 and week 2. Northern analysis
was performed using cDNA probes specific for PDGF receptor
a- and p-subunits.
Renal morphology
Tissue for light microscopy and immunoperoxidase staining was
fixed in methyl Carnoy's solution [211 and embedded in paraffin.
Three m sections were stained with the periodic acid Schiff
(PAS) reagent and hematoxylin. The percentage of glomeruli
exhibiting focal or global glomeruloscierosis was determined.
Glomeruloscierosis was evidenced by segmental increases in
glomerular matrix, segmental collapse and obliteration of cap-
illary lumina and accumulation of hyaline, and frequently was
associated with synechial attachments to Bowman's capsule.
Less commonly, these lesions also were associated with prom-
inence of visceral epithelial cells, and intracapillary micro-
thrombosis. Total glomerular cellularity was evaluated by
counting the total number of nuclei per glomerular cross sec-
tion. All glomerular cross sections present in a specimen were
evaluated. Sections of the glomerular tuft, in which the cross
sections had a very low cellularity (arbitrarily defined as < 50
cells/cross section), which are likely to represent tangential
sections, were excluded from the analysis.
Electron microscopy
Tissue for electron microscopy was fixed, processed and
examined as described previously [34]. Ultrastructural studies
were performed on two specimens each obtained at days 3 and
5 and week 1 after 5/6 nephrectomy (8, 10 and 9 glomeruli,
respectively, were evaluated in these specimens). Furthermore,
electron microscopy was performed on two specimens obtained
at day 3 and week 1 after sham operation (8 and 10 glomeruli
evaluated, respectively).
Immunohistochemistry
Four tm sections of methyl Carnoy's fixed biopsy tissue
were processed by an indirect immunoperoxidase technique or
an indirect immuno-alkaline phosphatase method (PDGF
B-chain) as previously described [21, 33]. Primary antibodies
included:
—19A2 (American Biotech Inc., Plantation, Florida, USA), a
murine 1gM monoclonal antibody against human PCNA,
which is expressed by actively proliferating cells. Nuclear
expression of PCNA is absent in the G0 and early G1 phase of
the cell cycle and increases in the late G1 and S phase,
followed by a decrease in G2/M [35].
—EDt (Bioproducts for Science, Indianapolis, Indiana, USA), a
murine monoclonal IgG to a cytoplasmic antigen present in
monocytes, macrophages and dendritic cells.
—RP-3 (gift of F. Sendo, Yamagata, Japan), a murine monoclo-
nal antibody to rat neutrophils [361.
—OX-22 (Accurate Chemical Corporation, Westbury, New
York, USA), a murine monoclonal antibody to the high
molecular weight form of the common leukocyte antigen
expressed on B-lymphocytes and most T-lymphocytes.
—PGF-007 (Mochida Pharmaceutical, Tokyo, Japan), a murine
monoclonal antibody to a 25 amino acid peptide located near
the COOH-terminus of the human PDGF B-chain [37].
—a rabbit polyclonal antibody to the /3-subunit of the PDGF-
receptor as described elsewhere [33].
—a murine monoclonal antibody to an NH2-terminal synthetic
decapeptide of a-smooth muscle actin (gift of G. Gabbiani,
Geneva, Switzerland) [38].
For all biopsies, negative controls consisted of substitution of
the primary antibody with equivalent concentrations of an
irrelevant murine monoclonal antibody or normal rabbit IgG.
For each biopsy more than 15 consecutive cross sections of
cortical glomeruli containing more than 20 discrete capillary
segments each were evaluated by a blinded observer and mean
values per biopsy were calculated for the number of proliferat-
ing (PCNA +) cells, and for the various leukocyte populations.
A semiquantitative scoring system described elsewhere [39]
was used to grade the glomerular expression of PDGF-B chain
(PGF 007 immunoalkaline phosphatase staining). For the eval-
uation of the immunoperoxidase stains for a-smooth muscle
actin and PDGF receptor, each glomerulus was graded semi-
quantitatively as follows:
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o -Diffuse, very weak or absent staining of the glomerular
tuft. No localized increases of staining.
1+-Diffuse, weak staining with 1 to 25% of the glomerular tuft
showing focally increased staining.
2+-25 to 50% of the glomerular tuft demonstrating a focal,
strong staining.
3 + -50 to 75% of the glomerular tuft staining strongly in a focal
manner
4+->75% of the glomerular tuft staining strongly.
Immunohistochemical double-staining
Double immunostaining for the identification of the type of
proliferating cells was performed as reported previously [33] by
first staining the sections for proliferating cells with 19A2, an
1gM monoclonal antibody to PCNA, using an indirect immu-
nogold procedure. Sections were then incubated with the IgG1
monoclonal antibodies ED1, a monocyte/macrophage marker,
or OX-7 (Accurate Chemical Corporation), an antibody against
the Thy- 1.1 antigen present on the mesangial cell membrane.
Cells were identified as proliferating monocytes/macrophages
or mesangial cells if they showed positive nuclear staining for
PCNA and if the nucleus was completely surrounded by cyto-
plasm or cell membrane positive for either ED1 (monocyte/
macrophages) or OX-7 (mesangial cells). Proliferating cells in
which the PCNA positive nucleus did not border on a cyto-
plasm or cell membrane positive for ED! or OX-7 were classi-
fied as non-monocyte/macrophage or non-mesangial. Prolifer-
ating (PCNA+) cells which could not be clearly identified as
ED! or OX-7 positive or negative were considered non-classi-
fiable. Negative controls included omission of either of the
primary antibodies in which case no double-staining was noted.
Immunofluorescence staining
Immunofluorescence detection of glomerular fibrinogen was
carried out on 4 m sections of frozen kidney tissue using a
direct immunofluorescence procedure [40] with an FITC-cou-
pled goat anti-rat fibrinogen antibody (Organon-Teknika/Cap-
pel, Malvern, Pennsylvania, USA). Glomerular cross sections
were graded semiquantitatively as either "0" (indistinguishable
from control) or positive according to the extent of glomerular
fluorescence ("1+" < 25% of the tuft showing fluorescence,
"2+" 25 to 50%, "3+" 50 to 75% and "4+" > 75%).
In situ hybridization for PDGF B-chain
In situ hybridization was performed on 4 m sections of
biopsy tissue fixed in buffered 10% formalin utilizing a digoxi-
genin-labelled anti-sense cRNA probe for the murine PDGF
B-chain (derived from a cDNA, clone provided by Charles
Stiles, Boston) as described [39]. Detection of the cRNA probe
was performed with an alkaline phosphatase coupled anti-digoxi-
genin antibody (Genius Nonradioactive Nucleic Acid Detection
Kit, Boehringer-Mannheim, Mannheim, Germany) with subse-
quent color development. Controls consisted of hybridization
with a sense probe to matched serial sections, by hybridization
of the anti-sense probe to tissue sections which had been
incubated with RNaase A before hybridization, or by deletion
of the probe, antibody or color solution [39].
'111n-labelled platelet studies
Glomerular platelet localization in control and remnant kid-
ney rats was quantified at day 5 and weeks 2 and 4. Platelets
were isolated for labelling from blood (6 ml) collected by
cardiac puncture into 1 ml of acid citrate dextrose and 4.2 ml
Ringer's citrate dextrose (pH 6.7) was added. Following cen-
trifugation at 250x g for 10 minutes at room temperature the
platelet rich plasma was removed and the pH adjusted to 6.7.
The platelet rich plasma was then centrifuged at 800X g for 20
minutes at room temperature and the pellet was washed with
Ca2Mg2free Hanks Balanced Salt Solution (HBSS), pH 6.7
(Irvine Scientific, Santa Ana, California, USA) and the platelets
were collected after centrifugation at 800 g for an additional 20
minutes. The platelet pellet was suspended in 2 ml HBSS, and
30 Ci of "In-oxine (Amersham, Arlington Heights, Illinois,
USA) were added. Further incubation and washing steps were
performed as described [41]. For each experiment 1 8 "In
labelled platelets were infused into a tail vein. Each infusion
also contained 0.5 pCi of '251-labelled [41] rat IgG (Miles,
Naperville, Illinois, USA) to quantify glomerular blood contam-
ination. One hour after the injection the number of platelets
accumulating in glomeruli was determined from the "In and
125j counts measured in blood and isolated glomeruli as de-
scribed [41, 42].
Preparation of glomerular RNA and Northern analysis of
PDGF receptor gene expression
Glomeruli were isolated by differential sieving [2!]. To affirm
that the isolation procedure did not select a subpopulation of
glomeruli, glomeruli were isolated from a kidney at four weeks
after 5/6 nephrectomy and the histological changes as well as
the number of PCNA and ED! positive cells were compared
with those in a simultaneous biopsy of the same kidney.
Isolated glomeruli showed similar pathological changes to those
observed in the biopsy tissue. Staining for PCNA and ED!
revealed 2.8 1.8 (PCNA) and 8.3 6.3 (ED!) positive cells in
intact isolated glomeruli (N = 30) which was in the range
observed in the renal biopsy taken prior to the glomerular
isolation (3.1 1.6 (PCNA) and 7.5 4.! (ED!) positive
cells/glomerular cross section; N = 30).
Total RNA was extracted from isolated glomeruli from three
separate groups of 10 operated and four sham-operated rats
each with RNAzol B' following the manufacturer's instructions
(CinnalBiotecx Laboratories, Friendswood, Texas, USA). The
RNA obtained was further purified by an overnight precipita-
tion in 3 M LiCI at —20°C, followed by a 30 minute centrifuga-
tion at 4°C and 12,000x g and a final washing step with 75%
ethanol. For Northern analysis the RNA was thawed, dena-
tured and 15 tg/lane were electrophoresed through a formalde-
hyde/agarose gel and transferred to a nylon filter (Hybond N,
Amersham) as described [34]. The cDNA probes used for
Northern analysis were as follows:
1) PDGF receptor a-subunit. A 7 and a 4.5 kb EcoRI
fragment of rat PDGF a-receptor cDNA from plasmid p802E
[43] was used for the detection of the 6.7 kb rat PDGF
a-receptor transcript.
2) PDGF Receptor 13-Subunit. A 5.1 kb EcoRI fragment of
mouse PDGF receptor /3-subunit cDNA from plasmid pIBI [44]
Fig. 1. A. Glomerular immunohistochemical staining scores
observed for a-smooth muscle actin in sham-operated (O--O) or 5/6
nephrectomized (—) rats. < 0.05 versus normal (N = 5
each). B. Immunohistochemical glomerular staining for a-smooth
muscle actin in a sham-operated rat and (C) in a 5/6 nephrectomized
rat at week 2 after the operation. Glomerular staining is absent in the
control, while multiple glomerular cells stain positive in the operated
rat. Immunoperoxidase with methyl green counterstain, x400.
was used to detect the 5.7 kb rat PDGF receptor /3-subunit
transcript.
3) 28S ribosomal RNA. A bovine 280 bp cDNA probe was
used to detect 28S ribosomal RNA (provided by Dr. Luisa
Iruela-Arispe and Dr. Helene Sage).
All probes were labelled with [a-32P]-deoxycytidine 5-
triphosphate (3000 Ci/mmol, New England Nuclear, Boston,
Massachusetts USA) by random primer extension. Positive
controls included total RNA isolated from 5-HT cells (PDGF
receptor a-subunit; gift of Hiroshi Okazaki) and murine
BALB/c 3T3 fibroblasts (PDGF receptor /3-subunit).
Membranes were prehybridized and hybridized as described
[341 and autoradiograms were obtained and read by linear
densitometry [34]. All Northern analyses were repeated two to
three times with glomerular RNA preparations obtained from
different sets of animals. Some membranes were rehybridized
with additional probes (up to a maximum of 4x) [34].
Quantitation of PDGF receptor mRNA
Glomerular mRNA levels for pools of 10 remnant kidneys or
four control kidneys were quantified by slot-blot analysis pre-
pared with 2, 1 and 0.5 tg of each RNA sample and control
RNAs. Aliquots were applied to wells of a slot-blot manifold
(Schleicher & Schuell, Keene, New Hampshire, USA) and
blotted onto nylon filters (Nytran', Schleicher & Schuell) under
vacuum. Fixation, prehybridization, hybridization and washing
conditions were identical with those used for Northern analysis.
Autoradiograms were then obtained and read by linear densi-
tometry. Densitometry readings were normalized for equivalent
amounts of 28S ribosomal RNA per lane as described [34].
Values are expressed as optical density units relative to the
specific mRNA level observed in glomerular RNA from normal
rats.
Miscellaneous measurements
Serum creatinine was measured using picric acid (Worthing-
ton Diagnosis, Freehold, New Jersey, USA) and urine protein
excretion was measured by a sulfosalicylic acid method [45]
using a whole serum standard (Lab Trol, Dade Diagnostics,
Aquado, Puerto Rico).
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Fig. 2. A. Prol(ferating cells (as defined by immunostaining for PCNA)
and (B) total number of cells per glomerular cross section in sham
operated rats (O--O) and rats with 5/6 nephrectomy (• •). <
0.05 versus normal (N = 5 each).
Statistical analysis
All values are expressed as mean SD unless stated other-
wise. Statistical significance (defined as P < 0.05) was evalu-
ated using the Student's t-test or one way analysis of variance
with modified i-tests performed using the Bonferroni correction
[46].
Results
Glomerular expression of a-smooth muscle acrin precedes the
onset of proliferation
Glomerular expression of a-smooth muscle actin was the
only variable studied which antedated the onset of glomerular
cell proliferation in the OP-group: while glomerular staining in
sham operated animals was either absent or confined to the base
of the glomerular tuft (Fig. lA,C), small areas of glomerular
staining were noted in 5/6-nephrectomized animals three days
after the operation (Fig. IC). At all later time points, staining for
I I I I I — —— I
0 2 4 6 8
Time, weeks after 5/6 nephrectomy
Fig. 3. Monocytes/macrophages (as defined by immunostaining for
EDJ) per glomerular cross section in sham operated rats (O--O) and
rats with 5/6 nephrectomy (• •). < 0.05 versus normal (N = 5
each).
a-smooth muscle actin remained significantly elevated in the
OP-group (Fig. lB,C).
Glomerular cell proliferation starts five days after renal
ablation
PCNA staining revealed that glomerular cell proliferation had
begun within five days of renal ablation and peaked at week 2
(Fig. 2). Thereafter proliferation slowly subsided but remained
above controls throughout the 10 weeks of the study. Total
10 glomerular cellularity was not significantly increased until two
weeks after ablation and continued to increase thereafter (Fig.
2). In contrast, controls showed no increase in total or prolif-
erating glomerular cells over the study period (Fig. 2).
Glomerular leukocyte infiltration follows cell proliferation
Figure 3 shows that glomerular localization of ED1-positive
monocytes/macrophages remained in the normal range at the
onset of glomerular cell proliferation with the first significant
increase occurring between week 1 and 2. Thereafter a slow,
continuous glomerular influx of monocyte/macrophages oc-
curred until 7.5 weeks following 5/6 nephrectomy. A further
increase of glomerular monocytes/macrophages was noted at
week 10 (Fig. 3). In contrast, glomerular neutrophil counts and
OX-22 positive B- or T-lymphocyte counts in the OP-group
remained within the normal range of 0.4 0.2 (neutrophils;
RP-3) and 0.8 0.2 (lymphocytes; OX-22) cells/glomerular
cross section at all time points (data not shown).
Increased glomerular cell proliferation reflects mostly
mesangial cell proliferation
To establish what proportion of proliferating glomerular cells
were mesangial cells, sections were stained for both the PCNA
and Thy 1.1 antigen (Table 1). The results revealed that in
sham-operated animals the majority of proliferating cells were
non-mesangial (no significant difference was observed between
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Table 1. Results of double immunostaining for PCNA and the Thy-
1.1 antigen on the mesangial cell surface in rats after 5/6
nephrectomy (OP) or sham-operated rats (SHAM)
Cells per glomerular cross section
Proliferating, Proliferating,
non-mesangial mesangial Not
Group (PCNA+, Thy-Il—) (PCNA+, Thy-l.l+) classifiable
SHAMa 0.35 0.24 0.18 0.06 0.18 0.07
OP week 1 0.95 0.36' 1.65 0.24" 0.61 0.20
OP week 2 0.61 0.22 1.43 0.31" 0.82 0.50"
OP week 4 0.43 0.15 0.40 0.16 0.38 0.11
OP week 10 0.39 0.10 0.11 0.02 0.04 0.02"
Results of double immunostaining for PCNA and the ED1 antigen
present on monocytes/macrophages in rats after 5/6 nephrectomy
(OP) or sham- operated rats (SHAM)
Cells per glomerular cross section
Proliferating, non- Proliferating,
monocyte/non- monocyte/
macrophage macrophage Not
Group (PCNA+, ED1—) (PCNA+, EDI+) classifiable
SHAME 0.61 0.08 0.09 0.05 0.05 0.01
OP week 1 3.54 0.58" 0.15 0.10 0.05 0.02
OP week 2 3.02 0.91" 0.21 0.16 0.12 0.07
OP week 4 1.67 0.45" 0.15 0.09 0.08 0.01"
OP week 7.5 0.85 0.32 0.69 0.31" 0.18 0.03"
OP week 10 0.33 014b 0.93 022b 0.25 005b
Data are mean SD.
a N = 8 for SHAM (composed of 4 biopsies obtained at day 3 and 4
biopsies obtained at week 10 after the sham operation; no difference
was noted between these timepoints). N = 5 for all other groups. Due
to the different staining technique total PCNA-positive cells per gb-
merulus are lower than those detected during immunoperoxidase stain-
ing for PCNA only (Fig. 2).b p < 0.05 versus SHAM
biopsies obtained in control rats at day 3 and at week 10; data
not shown). Following 5/6 nephrectomy the number of prolif-
erating mesangial cells increased 9.2- or 7.9-fold, respectively,
at weeks 1 and 2 and then returned to the normal range at week
10 (Table 1). Proliferating non-mesangial cells in the glomeruli
of 5/6 nephrectomized rats also increased transiently by 2.7-fold
at week 1 (Table 1). Since a significant glomerular influx of
either neutrophils or lymphocytes was excluded at these time
points (see above), these proliferating non-mesangial cells pre-
sumably represented monocyte/macrophages, podocytes, or
endothelial cells.
To identify the proliferating non-mesangial cells, double
immunostaining was performed with antibodies against PCNA
and the ED1 antigen present on monocyte/macrophages, since
these cells can still undergo one cell-cycle after extravasation
[47, 48]. The results demonstrated that monocytes/macro-
phages did not contribute to the early 2.7-fold increase of
proliferating non-mesangial cells noted at week 1: at any time
point up to week 4 proliferating monocytes/macrophages were
within the normal range in the OP-group (Table 1). In contrast,
at weeks 7.5 and 10 the number of proliferating monocytes/
macrophages per glomerular cross section increased signifi-
cantly in the OP-group (Table 1). At week 10 proliferating
monocyte/macrophages accounted for the majority of prolifer-
ating glomerular cells (Table 1).
Table 2. Quantification of platelets bound per glomerulus using "In-
labelled platelets (Methods) and immunofluorescent localization of
glomerular fibrinogena in rats after 5/6 nephrectomy (OP) or sham-
operated rats (SHAM)
Fibrinogen staining
Time Platelets per glomerulus" score'
point SHAM OP SHAM OP
Day 3 — — 1.3 0.2 1.1 0.1
DayS 38.2 14.5 74.8 41.1 1.2 0.1 1.3 0.2
Week I — — 1.0 0.2 2.0 06d
Week 2 36.6 6.3 78.3 13.1" 1.3 0.2 2.5 0.6"
Week 3 — — 1.1 0.1 2.6 0.6"
Week 4 40.7 11.6 135.6 41.2" 1.1 0.3 2.7 0.2"
Week 7.5 — — 1.2 0.2 3.1 0.5"
Week 10 — — 1.1 0.1 3.2 0.1"
Data are mean SD
a Mean glomerular score based on a semiquantitative scoring system
ranging from 0 (negative) to 4+ (>75% of the glomerular tuft showing
fluorescence)b N = 5 each except for day 5 when N = 10 each
C N = 5 each
d P < 0.05 versus SHAM group at the same time point
Podocytes (glomerular visceral epithelial cells) also appeared
unlikely to be responsible for the early 2.7-fold increase of
proliferating non-mesangial cells: in all glomerular sections
<0.5% of PCNA-positive nuclei in the SHAM or OP group
were localized at the outer edge of the glomerular tuft, compat-
ible with a podocyte location.
Glomerular platelet influx but not intraglomerularfibrinogen
deposition coincides with the onset of glomerular cell
proliferation
Quantification of intraglomerular platelets using '1In-la-
belled platelets showed a significant (P < 0.02 vs. SHAM)
increase at day 5 in the OP-group (Table 2). Gbomerular platelet
counts in the OP-group remained elevated in comparison to
sham-operated animals at week 2 and increased further at week
4 after 5/6 nephrectomy (Table 2).
Table 2 also shows that no increase in glomerular fibrinogen
deposition was detectable at day 3 in the OP-group. Also no
increase was noted at day 5, when glomerular cell proliferation
had already started. At all later time points the glomerular
fibrinogen content was significantly elevated in the OP-group
(Table 2).
Glomerular PDGF B-chain and PDGF receptor gene and
protein expression increase during glomerular cell
proliferation
The glomerular expression of PDGF B-chain mRNA and
protein paralleled the course of glomerular cell proliferation. As
shown in Figure 4A-C, the glomerular immunohistochemical
staining for PDGF B-chain protein in the OP-group was not
different from sham controls at day 3 but increased significantly
between weeks 1 to 7.5. No significant difference remained at
week 10. At week 2 after 5/6 nephrectomy Strong immunohis-
tochemical staining mainly localized to the cytoplasm of cells
within the glomerular tuft, although occasional, weaker staining
was also noted in the cytoplasm of cells in podocyte locations
(Fig. 4C). In situ hybridization for glomerular PDGF B-chain
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Fig. 5. In situ hybridization for the PDGF B-chain mRNA in
glomeruli of sham operated and 5/6 nephrectomized rats. In sham
operated rats, glomeruli were usually negative (A). At week 2 after
5/6 nephrectomy PDGF B-chain mRNA expression is present in
many glomerular cells (B). Rats at 10 weeks after 5/6 nephrectomy
had a pattern of staining similar to sham operated rats (C). (X310)
mRNA also demonstrated increased glomerular localization in
operated animals between weeks 1 and 4 (Fig. 5B), while no
glomerular staining was present in sham-operated rats or in
biopsies of the OP-group obtained at day 3, day 5, or week 10
(Fig. 5A,C).
The immunohistochemical staining for PDGF receptor 13-sub-
unit increased after the onset of glomerular cell proliferation in
OP-rats with the first significant difference compared to the
SHAM group occurring at week 2 (Fig, 4A,D,E). Increased
PDGF-receptor staining in a strongly mesangial pattern then
persisted at all subsequent time points examined in the OP-
group (Fig. 4A,D,E). Northern analysis of total glomerular
RNA isolated from either 5/6nephrectomized or sham operated
rats showed the presence of a typical 5.7 kb PDGF receptor
(3-subunit transcript in both groups (Fig. 6). Densitometric
quantification of mRNA levels by slot-blot analysis revealed a
1.4 0.1-fold increase (N = 3) of PDGF receptor 13-subunit
mRNA expression at week 2 in the OP-group, while no such
difference between operated and sham-operated rats was noted
at day 5. Expression of glomerular PDGF receptor a-subunit
mRNA could not be demonstrated by Northern analysis in
either group (data not shown).
Temporal relationship of glomerular ultrastructural
abnormalities to glomerular cell proliferation
Electron microscopy performed on specimens obtained at
days 3 and 5 and week 1 after 5/6 nephrectomy showed protein
reabsorption droplets in glomerular epithelial cells as early as
day 3. The number of protein reabsorption droplets then
gradually increased with time (Fig. 7A). No evidence of gb-
merular epithelial cell damage such as foot process effacement
or fusion was noted during the first week in the OP-group. Most
of the glomerular endothelial cells in operated rats showed a
normal ultrastructure, although endothelial cell swelling was
observed occasionally. The mesangium of operated rats ap-
peared normal prior to week 1. At week 1 occasional mesangial
hypercellularity and prominent mesangial channels, possibly
reflecting minor mesangiolysis, were present (Fig. 7B). Also, at
week 1 rare intracapillary platelet accumulations were noted. In
the specimens examined only one focus of fibrin tactoid accu-
mulation was present at week 1 in the OP-group in the urinary
space, while no fibrin clots were detectable within the capillary
lumina.
Progressive renal insufficiency, proteinuria and
glomeruloscierosis develop after the onset of glomerular cell
proliferation
Following the 5/6 nephrectomy, an immediate rise of serum
creatinine occurred in the rats of the OP-group (Table 3). Serum
creatinine then remained stable in this group until week 4 after
which a continuous further rise was noted (Table 3). Patholog-
ical proteinuria (defined as >25 mg/24 hr) was present in the rats
0
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Fig. 6. Left panel. Northern analysis of total glomerular RNA obtained
in rats at week 2 after sham-operation or 5/6 nephrectomy or of total
RNA from BALB/c 3T3 fibrosis (positive control) for the expression of
PDGF receptor /3-subunit mRNA. Right panel. Northern analysis of
total glomerular RNA obtained in rats at week 2 after sham-operation or
5/6 nephrectomy for the expression of 28S rRNA.
of the OP-group after week 2 (Table 3). SignifIcant light micro-
scopic changes of focal or diffuse glomerulosclerosis, as de-
scribed in the methods section, were absent at day 3 and week
1 after the operation and gradually increased thereafter in the
OP-group (Table 3).
Discussion
The first discernible pathological change we observed follow-
ing 5/6 nephrectomy was the intraglomerular expression of
a-sffiooth muscle actin. We have recently shown that the
glomerular expression of a-smooth muscle actin, which in the
normal mature rat kidney is expressed only by vascular smooth
muscle cells, reflects a mesangial cell phenotypic switch asso-
ciated with the induction of proliferation [34]. The observation
that glomerular a-smooth muscle actin expression in 5/6 ne-
phrectomized rats preceded detectable proliferation suggests
that mechanisms different from those that initiate proliferation
might be operative in the regulation of this actin isoform. One
such mechanism may be the rapid increase in glomerular
capillary pressure, GC, which occurs following 5/6 nephrec-
tomy [49] and which is transmitted to mesangial cells. How-
ever, the earliest timepoint after 5/6 nephrectomy at which P0
has been measured was one week [49] (at which time point it
was found to be elevated), and consequently it is possible that
glomerular pressures were not increased at three and five days.
Thus, we cannot exclude the possibility that non-hemodynamic
factors, such as humoral mediators [8], may be responsible for
the early changes observed after 5/6 nephrectomy.
Five days after renal ablation, an abrupt increase in prolifer-
ating cells in the glomerulus was observed, which preceded
significant proteinuria and glomerular sclerotic changes by one
to two weeks. Previous investigators have suggested that
mesangial cell proliferation may be responsible for this hyper-
cellularity [49, 50], but no direct evidence or quantitative data
have been provided. Double immunostaining in the present
study confirmed that most of the proliferating cells at one to two
weeks were indeed mesangial cells. A similar proliferation of
cells predominantly in a mesangial localization at 72 hours or
two weeks following 3/4 nephrectomy has also been detected in
the remnant kidney model by autoradiographic studies [18, 51].
We also found that non-mesangial proliferating cells increased
significantly at one to two weeks. Since these cells were not
infiltrating leukocytes and are unlikely to be epithelial cells [this
study and 18, 51, 52] it seems probable that they represented
endothelial cells, which in normal rats account for 70 to 80% of
the spontaneously proliferating cells [53]. Two previous auto-
radiographic studies in 3/4 nephrectomized rats showed prolif-
erating cells in endothelial cell locations [18, 51], although it
was not documented that proliferation of endothelial cells in
fact increased after renal ablation.
Previous studies in a model of hypertensive small vessel
injury have demonstrated that increases in pressure within
capillaries can cause endothelial cell injury and platelet accu-
mulation [54]. However, in the present study, despite a pre-
sumed rapid increase in glomerular capillary pressure P,
there were few ultrastructural indications of glomerular cell
damage prior to, or at the time of, the induction of proliferation.
In contrast to the lack of significant ultrastructural evidence for
glomerular endothelial or epithelial damage, rare intracapillary
platelet accumulations were detected one week after 5/6 ne-
phrectomy in a minority of glomeruli, suggesting that the
increased shear stress in the glomerular capillaries of these rats
led to alterations of the antithrombotic properties of the capil-
lary walls.
In the present study glomerular platelet accumulation, but
not thrombus formation (as evidenced by fibrinogen deposi-
tion), occurred at the same time point as the onset of glomerular
cell proliferation. Although the average glomerular platelet
accumulation was small compared to other models [41, 42] and
only correlated with the onset but not with the termination of
glomerular cell proliferation, our findings support the hypothe-
sis that glomerular platelet influx may be of pathogenetic
significance in the remnant kidney model. Platelets and intra-
glomerular coagulation have long been implicated in the devel-
opment of glomerular sclerosis in the renal ablation model [1, 3,
50]. Electron microscopic studies have repeatedly demon-
strated the presence of platelets and thrombi in glomerular
capillaries of rats with extensive renal mass ablation [3, 6, 50].
Glomerular thrombus formation and capillary obsolescence
have been regarded as the principal consequences of platelet
accumulation. However, another way in which platelets may
contribute to glomerulosclerosis is by releasing TGF-/3, which
has recently been shown to contribute to matrix accumulation
in a rat model of mesangioproliferative glomerulonephritis [55,
56]. These proposed roles for glomerular platelet accumulation
and coagulation have received support from a number of
pharmacological intervention studies. It has been shown that
treatment with different thromboxane synthase inhibitors,
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Fig. 7. Glomerular ultrastructure after 5/6 nephrectomy. At day 5 there are increased numbers of protein reabsorption droplets in glometular
visceral epithelial cells (A). x5320. At week 1 prominent mesangial channels are present (arrows) (B). x5930. C-capillary lumen, U-urinary space,
M-mesangial cell, P-podocyte.
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which have potent anti-platelet actions, ticlopidine, which
non-selectively inhibits several stimuli leading to platelet acti-
vation, or anticoagulants such as heparin and warfarin are all
able to retard the progression of glomeruloscierosis in the
remnant kidney model [23, 24, 27]. On the other hand, treat-
ment with a different TxA2 antagonist [251 or low dose aspirin
[57], which suppresses TxA2 dependent platelet aggregation but
not collagen-induced platelet degranulation [581, did not offer
any protection in this disease model. This indicates that other
platelet related mechanisms might also be of importance in the
progression of renal disease. Furthermore, N-desulfated/acety-
lated heparin, which completely lacks anticoagulant but retains
antiproliferative activity was nearly as protective as regular
heparin in 5/6 nephrectomized rats [26].
Apart from thrombus formation and release of substances
involved in matrix overproduction, such as TGF-f3, another
important role of platelets in glornerular diseases is the release
of growth factors potentially mediating glomerular cell prolifer-
ation. Such platelet-derived mitogens include PDGF, TGF-cxl
EGF, TGF-/3 in low concentrations as well as a recently
described endothelial cell growth factor [29—31, 59, 601. Indeed,
in vivo studies have shown that mesangial cell proliferation in
the Habu snake venom and the anii-Thy 1.1 model of mesan-
gioproliferative glomerulonephritis is mediated by platelets [21,
221.
The primary mitogen for cultured mesangial cells released
from activated platelets is PDGF [29—32, 59]. Apart from
platelets, PDGF A- and B-chains can also be produced by a
variety of other cells, including the mesangial cells themselves
[29], endothelial cells [61] and macrophages [281. An in vivo
role for PDGF in states of mesangial proliferation has been
suggested by the observations of increased glomerular PDGF
mRNA and protein expression in the anti-Thy 1.1 model of
mesangioproliferative glomerulonephritis [33, 39] as well as in a
mouse model of mesangial nephropathy [62]. Confirmation of
these hypotheses will require studies in which the effect of
selective PDGF blockers can be evaluated. Such studies are
now in progress. However, these findings suggest that platelet-
induced glomerular cell proliferation may become self-perpetu-
ating by an autocrine mechanism involving mesangial cell
production of PDGF. This concept of separate roles for PDGF
in initiation and maintenance of mesangial cell proliferation is
supported by the present study which shows that a detectable
increase in glomerular PDGF B-chain mRNA was first found 48
hours after the onset of proliferation and that thereafter the
gene and protein expression of PDGF B-chain was closely
correlated with the course of glomerular cell proliferation.
The cellular source of the increased PDGF mRNA expression
is likely to involve mesangial [29] as well as endothelial cells
[61] but not macrophages, which accumulated in the glomeruli
mainly at later stages. Our observation of immunostaining for
PDGF B-chain in occasional cells in podocyte locations would
suggest that these cells too may have contributed to the
increased glomerular expression of PDGF B-chain mRNA.
However, PDGF production by glomerular epithelial cells has
not been described. With respect to the mitogenicity of PDGF
for glomerular cells, in vitro data have shown that mesangial
Table 3. Basic characteristics of the renal ablation model: Serum
creatinine, urinary protein excretion and sclerosis index" in rats after
5/6 nephrectomy (OP) or sham-operated rats (SHAM)
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Fig. 8. Hypothetical pathogenetic scheme illustrating possible mech-
anisms related to the induction of glomerular cell proliferation as well
as consequences of glomerular cell proliferation following renal
ablation,
cells proliferate after stimulation with PDGF, indicating auto-
growth properties of PDGF n these cells [29—32, 59]. Endothe-
hal cells have classically been believed to be unresponsive to
PDGF. However, recent data obtained in cultured microvascu-
lar endothelial cells suggest that they also may proliferate in
response to PDGF [63]. In contrast to glomerular mesangial and
endothelial cells, cultured glomerular epithelial cells do not
show a mitogenic response to even high doses of PDGF-BB (J.
Floege, unpublished observations).
In contrast to PDGF, which presumably either alone or in
combination with other, yet unidentified mitogens was respon-
sible for the maintenance of proliferation in the present study,
the nature of the stimulus responsible for the initiation of
proliferation remains much more speculative. Possible candi-
dates include mitogens released from activated platelets [28—32,
59], shear stress-induced release of endothelial cell PDGF [61],
or bFGF [29] or yet unknown circulating "renotropins" [64].
Simultaneous with the increase of glomerular PDGF expres-
sion, increased immunohistochemical staining for the PDGF
receptor /3-subunit was noted in the mesangium of 5/6 nephrec-
tomized animals. In contrast, glomerular PDGF receptor 13-sub-
unit nRNA only showed a low grade increase. This later finding
may result from a combination of factors, including the inho-
mogenous glomerular involvement during the disease and the
fact that mesangial cells, that is, the main glomerular cells likely
to express PDGF receptors, only account for about 30% of the
glomerular cells. Furthermore, in a hypertrophied glomerulus
the cellular mRNA content will increase, implying that if 15 g
RNA is loaded per lane during Northern analysis this will
correspond to fewer cells than in control rats. Alternatively, the
discrepancy between the marked increase in PDGF receptor
immunostaining and the minor increase of PDGF receptor gene
expression could be due to post-transcriptional regulation of the
PDGF receptor expression. In the absence of reliable quantita-
tive data, it therefore remains speculative whether the in-
creased receptor protein and gene expression was merely a
reflection of the increase in mesangial cell numbers or whether
it did represent receptor overexpression. On the other hand our
findings demonstrate that total glomerular PDGF-receptor num-
bers increase not only during glomerular inflammation, as
suggested by earlier studies [33, 65], but also in non-inflamma-
tory diseases such as the renal ablation model.
The last event in the chronology of pathological findings
observed in the present study was a glomerular influx of
monocyte/macrophages, which occurred in parallel with the
onset of significant proteinuria and sclerotic changes. This
finding suggests that mesangial cell proliferation is not caus-
atively related to factors released by macrophages. Rather, the
glomerular monocyte/macrophage influx appears to be a sec-
ondary reaction. The late mononuclear cell infiltrate could be
driven by the release of chemoattractant factors such as PDGF
[1], glomerular complement activation, the release of monocyte
chemoattractant peptide (MCP-1/JE-protein) [66], or migration
inhibitory factor [67, 68] from activated endothelial cells or of a
recently described mesangial cell chemoattractant [69] from the
damaged glomerulus. If glomerular monocyte/macrophage in-
flux is viewed as a response to the early glomerular damage
including glomerular cell proliferation (that is, related to the
severity and extent of damage) this may explain why glomerular
macrophage numbers have been found to correlate with the
development of focal and segmental glomeruloscleosis in the
renal ablation model [18].
Based on the present findings and previous observations, we
suggest the following sequence of pathogenetic events in the
glomerulopathy that occurs in rats with severe renal ablation
(Fig. 8): Following extensive loss of renal mass the resulting
non-hemodynamic and/or adaptive hemodynamic changes, in-
cluding a rise in glomerular capillary pressure and shear stress,
induce a mesangial cell phenotype switch and activation, as
evidenced by the glomerular expression of a-smooth muscle
actin. Also, as a consequence of increased shear stress on the
endothelium, the antithrombotic properties of the capillary wall
may be altered. These glomerular alterations in turn facilitate
the glomerular localization and activation of platelets. Platelet
release products may constitute the "initiator signal" for
mesangial (and endothelial) cell proliferation. Alternatively, the
"initiator signal" may be derived from circulating humoral
factors or mitogens derived from intrinsic glomerular cells.
Subsequently, mesangial and endothelial cell proliferation be-
comes self-perpetuating by the endogenous production of
mesangial (and endothelial) cell PDGF in the presence of
increased glomerular PDGF receptor expression. Secondary to
the mesangial cell proliferation, matrix overproduction and
glomerular macrophage influx occur, both of which correlate
with the later development of glomerular sclerotic changes.
This theoretical model may provide a rationale for further
intervention studies specifically addressing the role of platelets
and/or PDGF in progressive renal disease.
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